Former Sonic Healthcare chairman Michael Boyd is offloading his luxury Melbourne bolthole, while Rokt co-founder Ben Voltz is selling his Toorak home ahead of Sydney move.| Australian Financial Review
The country’s biotech firms are one to two years away from US commercialisation, while drug makers are focused on the huge domestic market.| Australian Financial Review
A staggering 18,000 private capital funds are trying to raise trillions of dollars. Something’s got to give, according to the industry’s biggest players.| Australian Financial Review
Tech bros have taken to X in an extraordinary public spat to question each other’s financial muscle over Donald Trump’s $800b AI joint venture. Elon Musk said, “they don’t have the money”.| Australian Financial Review
UBS chief economist George Tharenou said public sector wages had more than doubled since 2008-09, keeping upward pressure on interest rates.| Australian Financial Review
Official figures show less than 1 per cent of residential home sales were to foreign investors, but One Nation and the Coalition want to know how many deals were blocked.| Australian Financial Review
The Albanese government wants to cut student debts as it frets about younger voters turning to the Greens. Economists say the $16b loan forgiveness will favour high earners.| Australian Financial Review
The Australian Financial Review reports the latest news from business, finance, investment and politics, updated in real time. It has a reputation for independent, award-winning journalism and is essential reading for the business and investor community.| Australian Financial Review
Investors are in panic as Australian drug companies could be the next victims in an expansion of the US trade war.| Australian Financial Review
